Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Goldstein

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
International Journal of Cardiology|January 23, 2016
Might ezetimibe be considered an expensive placebo?Luca Mascitelli, Mark R Goldstein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 30, 2014
Might intraplaque hemorrhage represent the proof-of-concept that iron plays a causal role in plaque vulnerability?Luca Mascitelli, Mark R Goldstein
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2014
Cancer death and antihypertensive drug treatment-letterMark R Goldstein, Luca Mascitelli
Medical Hypotheses|January 8, 2014
Hereditary hemochromatosis, iron, hepcidin, and coronary heart diseaseLuca Mascitelli, Mark R Goldstein
European Journal of Preventive Cardiology|February 21, 2012
Statin therapy in the elderly: might there be uncertainty in the majority?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Journal of Clinical Lipidology|February 5, 2011
Rebuttal to counterpointMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Archives of Medical Research|January 5, 2011
Role of ezetimibe in the prevention of cardiovascular disease: absence of evidenceLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 8, 2010
Explaining sex difference in coronary heart disease: is it time to shift from the oestrogen hypothesis to the iron hypothesis?Luca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Archives of Internal Medicine|November 25, 2010
Platelet inhibition and cancer promotionMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 9, 2009
Questioning the cardioprotective action of hormone replacement therapy in postmenopausal womenLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
International Journal of Cardiology|January 23, 2016
Might ezetimibe be considered an expensive placebo?Luca Mascitelli, Mark R Goldstein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 30, 2014
Might intraplaque hemorrhage represent the proof-of-concept that iron plays a causal role in plaque vulnerability?Luca Mascitelli, Mark R Goldstein
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2014
Cancer death and antihypertensive drug treatment-letterMark R Goldstein, Luca Mascitelli
Medical Hypotheses|January 8, 2014
Hereditary hemochromatosis, iron, hepcidin, and coronary heart diseaseLuca Mascitelli, Mark R Goldstein
European Journal of Preventive Cardiology|February 21, 2012
Statin therapy in the elderly: might there be uncertainty in the majority?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Journal of Clinical Lipidology|February 5, 2011
Rebuttal to counterpointMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Archives of Medical Research|January 5, 2011
Role of ezetimibe in the prevention of cardiovascular disease: absence of evidenceLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 8, 2010
Explaining sex difference in coronary heart disease: is it time to shift from the oestrogen hypothesis to the iron hypothesis?Luca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Archives of Internal Medicine|November 25, 2010
Platelet inhibition and cancer promotionMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 9, 2009
Questioning the cardioprotective action of hormone replacement therapy in postmenopausal womenLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Pageof 20